10/16/2019
6:18 PM | Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2019
6:14 PM | Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/22/2019
3:05 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2019
7:32 AM | Infinity Pharmaceuticals (Filer)
| Form 424B5
| |
07/30/2019
6:44 AM | Infinity Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2019
6:35 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2019
3:26 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2019
3:06 PM | EVNIN ANTHONY B (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:06 PM | Infinity Pharmaceuticals (Issuer)
SELBY NORMAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:06 PM | BEIER DAVID W (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:05 PM | Infinity Pharmaceuticals (Issuer)
VENUTI MICHAEL C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:05 PM | BLOCH LAWRENCE E (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:05 PM | Infinity Pharmaceuticals (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:05 PM | Infinity Pharmaceuticals (Issuer)
Perkins Adelene Q (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:05 PM | Berkowitz Jeffrey (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
6:32 AM | Infinity Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/13/2019
3:56 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2019
3:11 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2019
2:16 PM | Infinity Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2019
11:15 PM | Infinity Pharmaceuticals (Filer)
| Form EFFECT
| |
04/24/2019
7:30 AM | Infinity Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/08/2019
4:03 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2019
9:10 AM | Infinity Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/14/2019
6:38 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2019
6:06 AM | Infinity Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2019
6:53 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2019
7:00 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2019
3:07 PM | Infinity Pharmaceuticals (Issuer)
Tasker Seth A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
3:06 PM | BLOCH LAWRENCE E (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
3:05 PM | Infinity Pharmaceuticals (Issuer)
Kutok Jeffery (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
3:05 PM | Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
3:05 PM | Infinity Pharmaceuticals (Issuer)
Perkins Adelene Q (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
6:46 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2018
6:40 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
5:28 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2018
4:57 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2018
4:24 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
| Form SC 13D/A
| |
11/15/2018
7:07 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2018
2:33 PM | Infinity Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/30/2018
11:00 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2018
4:10 PM | Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2018
4:05 PM | Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/07/2018
3:13 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2018
2:27 PM | Infinity Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/26/2018
10:52 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2018
4:00 PM | Infinity Pharmaceuticals (Issuer)
Kutok Jeffery (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2018
5:57 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2018
4:23 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
| Form SC 13D/A
| |
06/14/2018
7:37 AM | Infinity Pharmaceuticals (Issuer)
SELBY NORMAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
7:35 AM | Berkowitz Jeffrey (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
7:34 AM | Infinity Pharmaceuticals (Issuer)
SMITH IAN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
7:33 AM | EVNIN ANTHONY B (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
7:32 AM | Infinity Pharmaceuticals (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
7:31 AM | Infinity Pharmaceuticals (Issuer)
VENUTI MICHAEL C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
7:30 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2018
7:30 AM | BEIER DAVID W (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2018
11:15 PM | Infinity Pharmaceuticals (Filer)
| Form EFFECT
| |
05/08/2018
3:12 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2018
2:36 PM | Infinity Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2018
3:55 PM | Infinity Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/25/2018
7:30 AM | Infinity Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/12/2018
4:29 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
| Form SC 13D
| |
04/11/2018
5:01 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2018
7:22 PM | BEIER DAVID W (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2018
7:18 PM | BEIER DAVID W (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/15/2018
3:17 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2018
2:43 PM | Infinity Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/08/2018
7:39 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2018
3:22 PM | Infinity Pharmaceuticals (Issuer)
Perkins Adelene Q (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2018
1:35 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/14/2018
7:49 AM | Flynn James E (Filed by)
Infinity Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/13/2018
8:39 AM | FMR LLC (Filed by)
Infinity Pharmaceuticals (Subject)
| Form SC 13G
| |
02/12/2018
8:38 AM | Infinity Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/08/2018
10:39 AM | Infinity Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
01/09/2018
3:10 PM | Infinity Pharmaceuticals (Issuer)
Perkins Adelene Q (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2018
7:41 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2017
8:11 AM | BLOCH LAWRENCE E (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
